We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
febit Joins the READNA Consortium with its Sequence Capture Technology
News

febit Joins the READNA Consortium with its Sequence Capture Technology

febit Joins the READNA Consortium with its Sequence Capture Technology
News

febit Joins the READNA Consortium with its Sequence Capture Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "febit Joins the READNA Consortium with its Sequence Capture Technology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

febit announces that the company will further advance its HybSelect technology for use in READNA projects. HybSelect enables automated capture of specific DNA regions for high-throughput sequencing and will soon be launched in several markets.

Joining a group of 16 European partners from industry and academics, febit will support the READNA consortium (REvolutionary Approaches and Devices for Nucleic Acid analysis).

In projects supported by the EU with 12 million Euros of funding, the consortium pursues the development and evaluation of trail-blazing new technologies for DNA sequencing.

febit CSO Peer Stahler is convinced that HybSelect will make an important contribution to these efforts: “Using our novel technology, we can quasi-automatically capture specific genes from samples, thus enabling highly efficient operation of next-generation sequencers by directing the sequencing process to the regions of interest to the researcher. Multiple samples may be sequenced in parallel for immediate analysis – saving time, cost and a great deal of effort in data analysis.“

For the research group of Dr. Ivo Gut, project coordinator and Associate Director of the Centre National de Genotypage (CNG) in Paris (France), febit will adapt its HybSelect technology for selected applications in next generation sequencing.

“We are very happy that we managed to get Europe’s most innovative researchers on board of the READNA project,“ Dr. Gut explains. “The project will help to advance biomedical science and open up new pathways in health care. The extraordinary quality of research in this consortium illustrates the importance and caliber of life sciences in Europe.“
Advertisement